MDS to Release Fourth Quarter and Year-End Results
10 Dicembre 2007 - 5:39PM
PR Newswire (US)
TORONTO, Dec. 10 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;
NYSE: MDZ), a leading provider of products and services to the
global life sciences markets, announced that the Company will
report fourth quarter and year-end results on Thursday December
13th. The Company will also host an analyst conference call with
Stephen P. DeFalco, President and Chief Executive Officer and
Douglas Prince, Executive Vice-President Finance and Chief
Financial Officer, to discuss the results with analysts. The call
will be webcast live at 9:30 am EST on December 13th. Interested
parties may access the live webcast by visiting the "Latest News"
section of the MDS home page at http://www.mdsinc.com/ and clicking
on the conference link. An audio archive of the call and the
presentation slides will also be available after the event on the
"Webcasts & Presentations" page in our "For Investors" section
of the MDS website. MDS Inc. is a global life sciences company that
provides market-leading products and services that our customers
need for the development of drugs and the diagnosis and treatment
of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
6,200 highly skilled people in 28 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Investors: Sharon Mathers,
Senior Vice-President, Investor Relations and External
Communications, MDS Inc., (416) 675-6777 x 34721, ; Media:
Catherine Melville, Director, External Communications, MDS Inc.,
(416) 675-6777 x 32265,
Copyright